logo

Selecta Biosciences Inc. (SELB)



Trade SELB now with
  Date
  Headline
7/15/2019 8:16:04 AM Selecta Biosciences Appoints Alison Schecter As Chief Medical Officer
3/15/2019 8:06:02 AM Selecta Biosciences Q4 Net Loss $14.7 Mln Or $0.65/Shr Vs Loss Of $19.5 Mln Or $0.88/shr Last Year
1/22/2019 4:04:26 PM Selecta Biosciences Announces Proposed Public Offering Of Common Stock
11/8/2018 8:12:57 AM Selecta Biosciences Q3 Net Loss Widens To $16 Mln From $14.7 Mln Last Year
10/23/2018 7:09:19 AM Selecta Biosciences Presents New Interim Data From Phase 2 Trial Of SEL-212 At ACR 2018
9/27/2018 7:37:29 AM Selecta Biosciences Appoints Carsten Brunn As President And CEO
8/8/2018 8:06:23 AM Selecta Biosciences Q2 Net Loss $18.8 Mln Or $0.84/Shr Vs Loss Of $16.0 Mln Or $0.85/Shr Last Year
6/15/2018 5:38:09 AM Selecta Biosciences Presents Data From Ongoing Phase 2 Trial Of SEL-212
5/9/2018 8:15:26 AM Selecta Biosciences Q1 Net Loss $15.9 Mln Or $0.71/shr Vs. Net Loss Of $15.1 Mln Or $0.82/shr Prior Year
4/10/2018 8:06:18 AM Selecta Biosciences Presents Positive New Data From Ongoing Phase 2 Trial Of SEL-212
3/12/2018 8:05:58 AM Selecta Biosciences: First Patient Dosed In Phase 1 Trial Of SEL-403 In Mesothelioma